Tirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist, designed for research into metabolic regulation. It is studied for its potential to enhance insulin sensitivity, reduce body weight, and improve glycemic control in preclinical models of type 2 diabetes and obesity. For laboratory research use only. Not for human consumption.
Tiraz
$100.00 – $375.00
+ Free ShippingTirzepatide is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist, designed for research into metabolic regulation. It is studied for its potential to enhance insulin sensitivity, reduce body weight, and improve glycemic control in preclinical models of type 2 diabetes and obesity. For laboratory research use only. Not for human consumption.
